EDGAR Filing Documents for 0001387131-22-007475

Form 8-K - Current report:

SEC Accession No. 0001387131-22-007475

Filing Date

2022-07-06

Accepted

2022-07-06 06:04:14

Documents

Period of Report

2022-06-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	admp-8k_063022.htm iXBRL	8-K	80618
2	CERTIFICATE OF DESIGNATION	ex3-1.htm	EX-3.1	115159
3	COMMON STOCK PURCHASE WARRANT	ex4-1.htm	EX-4.1	128024
4	SECURITIES PURCHASE AGREEMENT	ex10-1.htm	EX-10.1	240269
5	REGISTRATION RIGHTS AGREEMENT	ex10-2.htm	EX-10.2	175694
	Complete submission text file	0001387131-22-007475.txt		1069827

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	admp-20220630.xsd	EX-101.SCH	2935
7	XBRL LABEL FILE	admp-20220630_lab.xml	EX-101.LAB	34240
8	XBRL PRESENTATION FILE	admp-20220630_pre.xml	EX-101.PRE	22343
10	EXTRACTED XBRL INSTANCE DOCUMENT	admp-8k_063022_htm.xml	XML	3702

Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130

Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)